Faculty of Medicine

Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.

Classified as: Psychiatry, health and lifestyle, neuroproject, neuroprojects, neurofeedback, electroencephalograpy, placebo effects, psychological influences, social influences
Published on: 2 Jun 2016

McGill Newsroom

McGill alumnus tagged to boost capacity and discovery in growing field

Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.

Classified as: Pharmacology, epidemiology, Pharmacoepidemiology, health and lifestyle, growing, Albert Boehringer, David Eidelman
Published on: 27 May 2016

McGill Newsroom

Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.

Classified as: depression, pain, health and lifestyle, antidepressant, Jenna Wong, manoamine oxidase inhibitors, insomnia, panic disorders
Published on: 24 May 2016

By Shawn Hayward, Montreal Neurological Institute and Hospital

Discovery will aid development of treatments for this debilitating disease

Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.

Classified as: Guy Rouleau, MNI, Montreal Neurological Institute and Hospital, HSP, hereditary spastic paraplegia, gene mutation, debilitating disease, weakness, spasticity, CanHSP, Canadian Institutes for Health Research
Published on: 10 May 2016

McGill Newsroom

Discovery offers hope for more effective treatments of deadly glioblastomas

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.

Classified as: neuroscience, brain, Lady Davis Institute, science and technology, tumor, glioblastoma, tumour, Jahani-Asl, OSMR, neuroproject
Published on: 25 Apr 2016

McGill Newsroom

CREATE project to prepare graduates for high-skills work in surgical-devices industry

A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.

Classified as: Natural Sciences and Engineering Research Council of Canada, NSERC, Collaborative Research and Training Experience, science and technology, surgical-devices industry, Jake Barralet, Greg Fergus, Science and Economic Development, Rosie Goldstein
Published on: 14 Apr 2016

By Fergus Grieve, McGill Newsroom

Depression, metabolic factors combine to boost risk of developing diabetes, study finds 

Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.

Classified as: health, depression, diabetes, Norbert Schmitz, metabolic disease, Institut de recherches cliniques de Montréal, type 2, Molecular Psychiatry, neuroproject
Published on: 12 Apr 2016

By Tod Hoffman, Lady Davis Institute 

Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform

Classified as: Research, DNA, faculty of medicine, HIV, McGill News, CRISPR, gene-editing, Cell Reports, résistance, antiviral, Chen Liang
Published on: 8 Apr 2016

McGill University Health Centre

RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities

RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities

Classified as: children, disabilities, McGill University Health Centre, health and lifestyle, Annette Majnemer, brain-based development disabilities, SPOR, Jane Philpott, Steven Miller, Dan Goldowitz
Published on: 31 Mar 2016

McGill Newsroom

McGill, UCLA study of low- and middle-income countries shows paid maternity leave policies could help prevent infant deaths

For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.

Classified as: Biostatistics, Jody Heymann, Department of Epidemiology, health and lifestyle, maternity, UCLA Fielding School of Public Health, PLoS Medicine, child death, maternal death, and Occupational Health, McGill’s Institute for Health and Social Policy, Arijit Nandi
Published on: 30 Mar 2016

McGill Newsroom

Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications

Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.

Classified as: drugs, jewish general hospital, diabetes, Lady Davis Institute (LDI), Canadian Institutes of Health Research (CIHR), health and lifestyle, New England Journal of Medicine, Heart failure, incretin, Canadian Network for Observational Drug Effect Studies, Drug Safety and Effectiveness Network
Published on: 24 Mar 2016